Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304758445> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4304758445 endingPage "481" @default.
- W4304758445 startingPage "473" @default.
- W4304758445 abstract "Cyclooxygenase 2 (COX-2) is responsible for the therapeutic effects of indomethacin, while inhibition of the COX-1 enzyme and oxidative stress are responsible for its gastro-toxic effects. It has been reported that pycnogenol increases the expression of COX-1, suppresses the expression rate of COX-2 and oxidative stress. Our aim in this study is to investigate the antiinflammatory activities of indomethacin, pycnogenol, and their combination (PI) in rats and to examine their effects on stomach tissue. In the study, anti-inflammatory activity was investigated in carrageenan-induced inflammatory paw edema in albino Wistar male rats. Effects on stomach tissue were performed by applying the previous method. PI, indomethacin and pycnogenol were the best suppressors of carrageenan inflammation and oxidative stress in paw tissue, respectively. While the groups with the lowest COX-1 activity in paw tissue were IC, PIC and PC, respectively, PIC, IC and PC were the ones that best inhibited the increase in COX-2 activity. Pycnogenol inhibited the increase of malondialdehyde, the decrease of total glutathione and COX-1 in the stomach, and significantly suppressed the formation of indomethacin ulcers. Our experimental results showed that pycnogenol reduced the toxic effect of indomethacin on the stomach and increased anti-inflammatory activity. This beneficial interaction of pycnogenol and indomethacin suggests that PI will provide superior success in the treatment of inflammatory diseases." @default.
- W4304758445 created "2022-10-13" @default.
- W4304758445 creator A5004146187 @default.
- W4304758445 creator A5004433742 @default.
- W4304758445 creator A5007925869 @default.
- W4304758445 creator A5012115551 @default.
- W4304758445 creator A5036857735 @default.
- W4304758445 creator A5039445496 @default.
- W4304758445 creator A5045752510 @default.
- W4304758445 creator A5063283924 @default.
- W4304758445 creator A5076452942 @default.
- W4304758445 date "2022-01-01" @default.
- W4304758445 modified "2023-10-14" @default.
- W4304758445 title "Beneficial interaction of pycnogenol with indomethacin in rats" @default.
- W4304758445 doi "https://doi.org/10.4149/gpb_2022030" @default.
- W4304758445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36222345" @default.
- W4304758445 hasPublicationYear "2022" @default.
- W4304758445 type Work @default.
- W4304758445 citedByCount "0" @default.
- W4304758445 crossrefType "journal-article" @default.
- W4304758445 hasAuthorship W4304758445A5004146187 @default.
- W4304758445 hasAuthorship W4304758445A5004433742 @default.
- W4304758445 hasAuthorship W4304758445A5007925869 @default.
- W4304758445 hasAuthorship W4304758445A5012115551 @default.
- W4304758445 hasAuthorship W4304758445A5036857735 @default.
- W4304758445 hasAuthorship W4304758445A5039445496 @default.
- W4304758445 hasAuthorship W4304758445A5045752510 @default.
- W4304758445 hasAuthorship W4304758445A5063283924 @default.
- W4304758445 hasAuthorship W4304758445A5076452942 @default.
- W4304758445 hasBestOaLocation W43047584451 @default.
- W4304758445 hasConcept C126322002 @default.
- W4304758445 hasConcept C181199279 @default.
- W4304758445 hasConcept C185592680 @default.
- W4304758445 hasConcept C2776151105 @default.
- W4304758445 hasConcept C2776914184 @default.
- W4304758445 hasConcept C2778401633 @default.
- W4304758445 hasConcept C2779422922 @default.
- W4304758445 hasConcept C2779689624 @default.
- W4304758445 hasConcept C2780886150 @default.
- W4304758445 hasConcept C2781227287 @default.
- W4304758445 hasConcept C538909803 @default.
- W4304758445 hasConcept C55493867 @default.
- W4304758445 hasConcept C71924100 @default.
- W4304758445 hasConcept C98274493 @default.
- W4304758445 hasConceptScore W4304758445C126322002 @default.
- W4304758445 hasConceptScore W4304758445C181199279 @default.
- W4304758445 hasConceptScore W4304758445C185592680 @default.
- W4304758445 hasConceptScore W4304758445C2776151105 @default.
- W4304758445 hasConceptScore W4304758445C2776914184 @default.
- W4304758445 hasConceptScore W4304758445C2778401633 @default.
- W4304758445 hasConceptScore W4304758445C2779422922 @default.
- W4304758445 hasConceptScore W4304758445C2779689624 @default.
- W4304758445 hasConceptScore W4304758445C2780886150 @default.
- W4304758445 hasConceptScore W4304758445C2781227287 @default.
- W4304758445 hasConceptScore W4304758445C538909803 @default.
- W4304758445 hasConceptScore W4304758445C55493867 @default.
- W4304758445 hasConceptScore W4304758445C71924100 @default.
- W4304758445 hasConceptScore W4304758445C98274493 @default.
- W4304758445 hasIssue "05" @default.
- W4304758445 hasLocation W43047584451 @default.
- W4304758445 hasLocation W43047584452 @default.
- W4304758445 hasOpenAccess W4304758445 @default.
- W4304758445 hasPrimaryLocation W43047584451 @default.
- W4304758445 hasRelatedWork W1860085360 @default.
- W4304758445 hasRelatedWork W2070656560 @default.
- W4304758445 hasRelatedWork W2090651765 @default.
- W4304758445 hasRelatedWork W2365322489 @default.
- W4304758445 hasRelatedWork W2409784700 @default.
- W4304758445 hasRelatedWork W2566694324 @default.
- W4304758445 hasRelatedWork W3003588602 @default.
- W4304758445 hasRelatedWork W3006758926 @default.
- W4304758445 hasRelatedWork W3195158057 @default.
- W4304758445 hasRelatedWork W4315491170 @default.
- W4304758445 hasVolume "41" @default.
- W4304758445 isParatext "false" @default.
- W4304758445 isRetracted "false" @default.
- W4304758445 workType "article" @default.